Medicare Enrolled
Dr. Jason Bradley, M.D.
Interventional Cardiology · Lubbock, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bradley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bradley? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bradley
Dr. Jason Bradley is an interventional cardiology in Lubbock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Bradley performed 24,359 Medicare services across 10,057 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bradley received a total of $95,258 from 56 pharmaceutical and/or device companies across 852 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bradley is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in TX$ $95,258 industry payments
Medicare Practice Summary
Medicare Utilization ↗24,359
Medicare services
Top 1% in TX for interventional cardiology
10,057
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,282 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 11,044 | $45 | $62 |
| Office visit, established patient (20-29 min) | 2,775 | $60 | $176 |
| Electrocardiogram (EKG), 12-lead | 2,729 | $10 | $41 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,264 | $42 | $139 |
| Remote patient monitoring management, 20 min/month | 961 | $35 | $54 |
| Remote patient monitoring device, 30 days | 737 | $36 | $69 |
| Echocardiogram, transthoracic | 700 | $97 | $539 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 374 | $46 | $60 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 333 | $324 | $1,145 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 295 | $47 | $183 |
| Ultrasound of leg arteries or artery grafts | 271 | $145 | $615 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 260 | $93 | $494 |
| Ultrasound of both sides of head and neck blood flow | 253 | $106 | $480 |
| Ultrasound study of arm and leg arteries | 248 | $42 | $210 |
| New patient office visit (45-59 min) | 234 | $109 | $398 |
| Cardiac catheterization | 168 | $176 | $776 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 147 | $38 | $123 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 145 | $195 | $500 |
| Hospital follow-up visit, moderate complexity | 137 | $61 | $177 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 102 | $8 | $26 |
| Ultrasonic guidance for blood vessel access | 97 | $30 | $76 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 88 | $109 | $467 |
| Coronary stent placement | 73 | $411 | $1,509 |
| Ultrasound scan of abdominal aorta | 66 | $87 | $225 |
| Initial hospital admission, high complexity | 60 | $133 | $496 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 56 | $74 | $286 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 52 | $11 | $36 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 51 | $130 | $518 |
| Removal of plaque in arteries of leg | 47 | $5,607 | $25,925 |
| Hospital discharge day management, 30 minutes or less | 45 | $62 | $177 |
| Removal of plaque in artery of leg, initial vessel | 44 | $6,471 | $25,569 |
| Ultrasound of one leg arteries or artery grafts | 44 | $82 | $362 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 41 | $14 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $16 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 35 | $20 | $100 |
| Hospital follow-up visit, high complexity | 35 | $89 | $255 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 30 | $202 | $874 |
| New patient office visit (30-44 min) | 29 | $64 | $260 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 25 | $726 | $3,289 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 24 | $83 | $273 |
| Review by radiologist of arm or leg artery image | 22 | $112 | $378 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 21 | $29 | $129 |
| Removal of plaque and insertion of stents in arteries of leg | 20 | $8,536 | $35,005 |
| Insertion of stent in vein with review by radiologist, initial vein | 20 | $2,624 | $9,893 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 19 | $1,105 | $3,794 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 19 | $8 | $51 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 19 | $17 | $85 |
| Office visit, established patient (30-39 min) | 16 | $75 | $259 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | 13 | $160 | $533 |
| Insertion of tube into extracranial artery for diagnosis or treatment with review by radiologist | 12 | $286 | $5,500 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $103 | $635 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 12 | $145 | $670 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.2% high complexity
12.8% medium
83.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$95,258
Total received (2018-2024)
Avg $13,608/year across 7 years
Top 7% in TX for interventional cardiology
56
Companies
852
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$68,607 (72.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,478 (17.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,173 (10.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,370
2023$1,565
2022$8,225
2021$17,674
2020$9,379
2019$29,003
2018$28,043
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$25,178
AstraZeneca Pharmaceuticals LP
$17,984
PFIZER INC.
$12,933
E.R. Squibb & Sons, L.L.C.
$9,295
Cardinal Health 200, LLC
$7,069
Boston Scientific Corporation
$4,935
Avinger Inc.
$3,435
Abbott Laboratories
$1,884
Cardinal Health 200 LLC
$1,800
CORDIS US CORP.
$1,681
Amgen Inc.
$1,154
Medtronic Vascular, Inc.
$1,150
Shockwave Medical, Inc
$1,088
BOSTON SCIENTIFIC CORPORATION
$857
Medtronic, Inc.
$821
Janssen Pharmaceuticals, Inc
$486
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$382
Penumbra, Inc.
$343
Gilead Sciences, Inc.
$257
Cardiovascular Systems Inc.
$241
SANOFI-AVENTIS U.S. LLC
$232
AngioDynamics, Inc.
$205
Boehringer Ingelheim Pharmaceuticals, Inc.
$162
Merck Sharp & Dohme LLC
$134
CVRx, Inc.
$131
TRUVIC MEDICAL, INC.
$126
Endologix LLC
$125
Philips Electronics North America Corporation
$120
CHF Solutions, Inc
$113
ABIOMED
$101
Terumo Medical Corporation
$96
ShockWave Medical, Inc
$76
Novo Nordisk Inc
$63
Innovation Technologies Inc
$59
Actelion Pharmaceuticals US, Inc.
$48
Daiichi Sankyo Inc.
$46
Tactile Systems Technology Inc
$41
Merck Sharp & Dohme Corporation
$36
Philips North America LLC
$34
Lexicon Pharmaceuticals, Inc.
$33
Esperion Therapeutics, Inc.
$31
Amarin Pharma Inc.
$27
Teleflex LLC
$27
Endologix, LLC
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
Surmodics, Inc.
$23
Astellas Pharma US Inc
$22
Bayer HealthCare Pharmaceuticals Inc.
$20
Alnylam Pharmaceuticals Inc.
$20
Kiniksa Pharmaceuticals International, plc
$16
Regeneron Healthcare Solutions, Inc.
$14
BIOTRONIK INC.
$12
W. L. Gore & Associates, Inc.
$12
Kowa Pharmaceuticals America, Inc.
$12
ARALEZ PHARMACEUTICALS US INC.
$11
Bardy Diagnostics, Inc.
$8
Top 3 companies account for 58.9% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (6554) Peripheral Vascular Undivided · (6571) Eagle Eye · (BI2) IGT Systems Undivided · (P84) IGT Devices Systems · ABRE · AFX · ANGIOJET · APEX · AVANTI Sheath Introducer · AVVIGO Guidance System · Absolute Pro vascular stent system · AngioSeal · Aquadex · Arcalyst · BRILINTA · BRITE TIP RADIANZ · Barostim Neo System · CAMZYOS · CHANTIX · CHOCOLATE PTA BALLOON CATHETER · CLINICAL TRIAL PRODUCT · COMET · COREVALVE EVOLUT R · COROFLOW · COYOTE · Carnation Ambulatory Monitor · Catheter - GuideLiner · ClosureFast · Comet · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · ELIQUIS · ELUVIA · ENDOCROSS Device · ENTRESTO · EVERFLEX PROTG EVERFLEX · EluNIR Radaforolimus Eluting Coronary Stent System · Emerge Push · Endurant · FARXIGA · FILTERWIRE EZ · FLEXITOUCH · FilterWire EZ · Flexitouch Plus · GENERAL BALLOONS · GENERAL STENTS · GENERAL METALLIC STENTS · GENERAL ULTRASOUND · GENERAL VASCULAR INTERVENTION · GENERAL - ATHERECTOMY · GENERAL ATHERECTOMY · GENERAL GUIDEWIRES · GRAFTMASTER · GUIDEZILLA · General - Therapies · Guidezilla · HAWKONE · HawkOne · IGT_D Peripheral · ILAB · IN.PACT ADMIRAL · IN.PACT Admiral · INJECTAFER · INNOVA · IRRISEPT · Impella · Indigo System · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LifeVest · Livalo · MINI TREK · MOZEC TM · MULTAQ · MYNX CONTROL · MYNX CONTROLTM · MynxGrip Vascular Closure Device · NEXLETOL · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPTEASE Retrievable Vena Cava Filter · OPTICROSS · OPTIS · Onyx · OptiCross · Ozempic · PANTHERIS · PERCLOSE PROGLIDE · POWERFLEX · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRECISE PRO RX · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Peripheral RotaLink Plus · Pounce Thrombectomy · RAIN SHEATH TRANSRADIAL · ROTABLATOR · ROTALINK · ROTAPRO · Ranexa · Repatha · Resolute · S.M.A.R.T. · S.M.A.R.T. CONTROL · S.M.A.R.T. Flex Stent · SABER · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERA · SYNERGY · Supera peripheral stent system · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TURBOHAWK · TurboHawk · VERQUVO · VIABAHN Endoprosthesis with Heparin Bioactive Surface · VYNDAQEL · Vascepa · Vascular Lithotripsy · Wegovy · Wolverine Coronary Cutting Balloon · XACT · XARELTO · XIENCE SIERRA · XIENCE SKYPOINT · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for interventional cardiology in TX.
Equivalent to $391 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
5
Per 100K population
23.3
County median income
$54,810
Nearest hospital
LUBBOCK HEART HOSPITAL LP
6.5 mi
6.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bradley is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 7%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bradley experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Bradley performed 11,044 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bradley receive payments from pharmaceutical companies?
Yes. Dr. Bradley received a total of $95,258 from 56 companies across 852 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bradley's costs compare to other interventional cardiologys in Lubbock?
Dr. Bradley's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bradley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Lubbock
Browse interventional cardiologys in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology